> Welcome to community Information > Cancer Care Technologies > Technology in Surgery and Therapy > Index: All Articles
An estimated 200,000 Australian women are living with breast cancer.
It is the most common malignancy amongst women worldwide. One in eight Australian women are annually diagnosed with breast cancer. That is approximately 17,210 Australian women and 148 men diagnosed with breast cancer in 2020.
Radiation therapy designed technology provides a major support role to surgery and chemotherapy for breast cancer treatment.
For a quick tag, click on:
Deep Inspiration Breath Hold (DIBH)
Remote Seed Implant Guidance for Breast Cancer Surgery
Technology Research for Breast Cancer
———————————————————-
Breast Cancer Incidence
Setting up a breast cancer patient
for radiotherapy
The number of women with breast cancer will increase as our population ages. For example, the Australian Institute of Health and Welfare (AIHW) projected the daily number of new breast cancer cases would increase from 37 to 47 women by 2020. They have proven to be correct.
……..Read more
Deep Inspiration Breath Hold (DIBH)
Deep Inspiration Breath Hold (DIBH)
for Breast Treatment
The use of external beam radiotherapy for breast cancer has improved significantly in recent years. The course of radiotherapy is necessary to kill any microscopic disease that may have been left behind after your surgery. The X-ray dose to the surrounding lung and heart structures, should be as low as possible. To do this…..Read more
Remote Seed Implant Guidance for Breast Cancer Surgery
Guide helps Surgeon to accurately
locate breast tumour during the operation
Read about a new technology method that can replace the less desirable wire insert into breast method. It’s using a device called ‘Savi Scout’ and was FDA approved in 2015 -16.
………Read more
Technology Research for Breast Cancer
Cancer Goggles for Surgery
Goggles for guidance
during breast cancer surgery.
The cancer goggles were described as: “requiring the patient to have a bio-luminescent marker injected about one hour before the operation. The marker ‘dye’ attaches to the cancer cells. The surgeon wears the specially designed goggles during the operation and sees the malignant tumour cells glow when a near infrared light is beamed onto the patient.” (reported on Fox2Now, 9 February 2016)
The procedure was described as: “requiring the patient to have a bio-luminescent marker injected about one hour before the operation. The marker ‘dye’ attaches to the cancer cells. The surgeon wears the specially designed goggles……..Read more
> Welcome to community Information > Cancer Care Technologies > Technology in Surgery and Therapy > Index: All Articles
